baber/WOPTO huggingface dataset:
Patent FI-884517-A0 (FI)
Inventor: SPAHNI JR MILTON DANIEL
IPC: B65D5/70
Filed: 1988-09-30
Abstract: A reclosable dispensing package (10) which has a thin plastic fitment (44) mounted over a cutout area in the closure flaps of a seal end carton. The fitment is affixed to the outer (last-folded) major flap (18b). When the carton is in flattened tubular form, the caliper of the fitment-equipped closure flaps is minimized by providing a second cutout area in the inner (first-folded) major flap, sized and located to receive a projecting end of the fitment therein. Minimizing caliper permits shipment in more compact form and enables packing machine operators to place greater numbers of cartons in the machine hoppers.
Patent FI-892976-A0 (FI)
Inventor: HUBERTSON FOLKE
IPC: F16K5/20
Filed: 1989-06-16
Abstract: A valve with a valve body (11, 43) in the form of a ball or of a segment of a ball has a second, concave, spherical sealing surface (20, 53) which is provided to be resiliently urged against a first sealing surface of the valve body, and at least an outer, cylindrical surface (21, 65, 66) which slidingly contacts a cylindrical guiding surface (22, 55, 56) of equal diameter in the central part of the valve housing. A spring washer (17, 82) abuts an end surface (24, 73) of the seat ring and is firmly clamped with its peripheral portion between an end surface (27, 81) of the central part of the valve housing and an end surface (28, 62) of an end fitting. The end surface of the seat ring comprises an annular abutment surface (24, 73) at a radial distance from an interior of the peripheral portion of the spring washer. The abutment surface is projected in the axial direction toward the end fitting relative to a first, annular portion (23, 70) of said end surface of the seat ring.
Patent FI-896300-A0 (FI)
Inventor: PERREGAARD JENS
IPC: A61K31/40
Filed: 1989-12-28
Abstract: The invention relates to novel compounds of the formula: <CHEM>  wherein R<1>, R<2>, X and "Ar" are as defined in Claim 1; as well as pharmaceutically acceptable acid addition salts and stereo isomeres thereof. The compounds are described as having central sterotonin activity with preference for the serotonin 5-HT1A receptors, which indicates usefulness in the treatment of CNS disorders, including anxiety, depression and aggression, or in diseases related to cardiovascular, gastrointestinal and renal systems. Also methods of preparing said compounds and pharmaceutical compositions containing same are described.
Patent FI-904828-A0 (FI)
Inventor: VAN DEDEM GIJSBERT WILLEM KARE
IPC: A61K35/39
Filed: 1990-10-01
Abstract: The present invention relates to sulphated glycosamino glycuronan with antithrombotic activity consisting essentially of salts of dermatan sulphate, chondroitin sulphate and heparan sulphate, characterized by     a) an average molecular weight between 4000 and 8000 daltons;   b) a nitrogen content between 2.4 and 3.0%;   c) a sulphur content between 7.5 and 9.5%;   d) a sodium content between 9 and 11%;   e) a dermatan sulphate content between 5 and 25%;   f) a chondroitin sulphate content less than 9%;   g) an anti-Xa activity between 11 and 20 u/mg; and h) an antithrombin III dependent antithrombin activity of less than 1 u/mg. p
Patent FI-912200-A0 (FI)
Inventor: OLSEN ROBERT
IPC: B65D67/02
Filed: 1991-05-07
Abstract: Carrier stock (10) is formed from a single sheet of resilient polymeric material, such as low density polyethylene, for machine application to side walls of substantially identical containers (12). Integrally joined band segments (22,24,26,28,32,34,36,40) defining separate apertures (14) to receive the individual containers (12) include longitudinal (22,24), cross (32,34,36,40), and diagonal (26,28) segments. The diagonal segments (26,28) are joined together at generally X-shaped junctions (42). From each junction (42), the generally oblique segments of a first pair (26a,28a) are continuously curved toward the nearer edge of such stock (10) and the diagonal segments of a second pair (26b,28b) are substantially straight and tend toward the other edge of such stock. Each diagonal segment (26a, 28a) of the first pair at each junction has a progressively changing width, being wider at its end (48) joined at such junction (42) than at its other end (46). Each diagonal segment (26b,28b) of the second pair at each junction has a substantially uniform width. <IMAGE>
Patent FI-912854-A0 (FI)
Inventor: VALKO JOSEPH THEODORE
IPC: C08G18/58
Filed: 1991-06-13
Abstract: A cationic resin containing blocked isocyanate groups which is suitable for use in electrodeposition is disclosed. The cationic resin is derived from an epoxy resin and contains in the resin molecule cationic salt groups, active hydrogen groups and blocked isocyanate groups. The blocked isocyanate groups are incorporated into the resin molecule by reacting the epoxy resin with a compound selected from the class consisting of mercapto compounds and acid group-containing compounds where the compounds also contain blocked isocyanate groups. The resin can be formulated into an electrocoating composition which is free of lead and yet provides outstanding corrosion resistance when electrodeposited over steel substrates. The outstanding corrosion resistance can be attained when the substrate has not been given a chrome rinse which is conventional in pretreating the steel substrate before electrodeposition.
Patent FI-935853-A0 (FI)
Inventor: MEINANDER PAUL OLOF
IPC: D21D5/26
Filed: 1993-12-23
Abstract: PCT No. PCT/FI94/00578 Sec. 371 Date Jun. 19, 1996 Sec. 102(e) Date Jun. 19, 1996 PCT Filed Dec. 21, 1994 PCT Pub. No. WO95/17235 PCT Pub. Date Jun. 29, 1995A process and apparatus for pumping a fluid mixture of a gas and a liquid and for separating said gas and liquid from each other, said apparatus having a fluid inlet (14) at one end (18) and at the opposite end (22) a pump housing (16) with a liquid outlet (28) and, between said inlet (14) and said pump housing (16), a hollow elongated gas separation part (30) of an essentially circular cross section with a generally central outlet (26) for separated gas. Said gas separation part (30) is provided by a hollow rotor (12) between said inlet (14) and said pump housing (16), the inner wall of said rotor (12) providing a large rotatable gas separation surface (32). The diameter of said rotor (12) increases at said opposite end (22) of the apparatus to form a larger diameter pumping zone (17) extending into said pump housing (16). Said rotor (12) is provided with a blade wheel (24) extending into said pump housing (16). The apparatus is especially well suited for the gas-free re-cycling of backwater drained through a forming fabric in a papermaking process. The invention is also applicable to the removal of air from fluid materials separated by flotation.
Patent FI-942112-A0 (FI)
Inventor: VACCA JOSEPH P
IPC: C07F9/09
Filed: 1994-05-06
Abstract: Cpds. of formula (I) and their salts are new. In the formula X = OH or NH2; Z = O, S or NH; R = H or 1-4C alkyl; R1,R2 = e.g. H, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl (opt. substd. by 1 or more from 1-4C alkyl, OH and aryl), -w-aryl, -w-benzyl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl etc, or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = 3-10 member satd. monocyclic or bicyclic ring contg. 1-8C and 1 or more additional heteroatom (opt. substd.), or R1+N+R2 = 3-10C member satd. monocyclic or bicyclic ring contg. 209C, fused to Ph (opt. substd. by 1 or more from halo, 1-3C alkoxy, OH, 1-4C alkyl, NHR, (where R1 is not joined to R2) and NH-heterocycle; R3 = (CH2)R4, 1-4C alkenyl-R4 or 1-4C alkynyl R4; R4 = eg. H, 1-4C alkyl, 5-10 cycloalkyl (opt. substd. by OH), 6-10C aryl (opt. substd. by 1 or more from halo, OH, NO2, NR2, 1-4C, 1-3C alkoxy (opt. substd. by 1 or more from OH and 1-3C alkoxy), CO2R, CONR2, CH2NR2, CH2NHCOR, CN, CF3, NHCOR etc, B = absent or -NH-CH(R8)-C(=Z)-; J1,J2 = -YR9, N(R9)2, NR10R11 or -Y(CR9R12)n-R12; W = O, S or NH; n = 0-3; R8 = CHMe2, CH(me)Et or Ph; Y = O or NH; R9 = eg. H, 1-6C alkyl (opt. substd. by 1 or more from NR2, OR, NHSO2 (1-4Calkyl), NHSO2 aryl, NHSO2 (dialkylaminoaryl) etc., R10+N+R11 = 5-7 member heterocycle opt. contg. 1 additional heteroatom O, S or NR); R12 = eg. H, aryl (opt. substd. by 1 or more from R14, -1-4C alkyl-NR2 and OCO(1-4Calkyl) etc.. R14 = halo, OR, CONR2, CH2NR2, SO2NR2, NR2, NHCOR, 1-4alkyl, Ph, CF3, N(R)SO2R, OP(O)(ORx)2 or CO2R.
Patent FI-954480-A0 (FI)
Inventor: JOENSSON KURT
IPC: B01D29/88
Filed: 1995-09-21
Abstract: PCT No. PCT/SE94/00267 Sec. 371 Date Sep. 25, 1995 Sec. 102(e) Date Sep. 25, 1995 PCT Filed Mar. 24, 1994 PCT Pub. No. WO94/22547 PCT Pub. Date Oct. 13, 1994A suspension is delivered to a filter bed comprised of granular filter medium in a continuously working filter at the lower part of the bed and is then permitted to flow upwards through the bed. With the intention of optimizing the capacity of the filter, the suspension is now guided into a central region of the bed. The suspension is divided from this region into at least two specific proportional quantities which are each led from the filter bed in a respective ring-shaped pattern at mutually different heights in relation to the extension of the bed, these ring-shaped patterns having different diameters and each being adapted to the extension of the filter medium in the direction of the diameter.\!
Patent FI-963612-A0 (FI)
Inventor: KINNUNEN PAAVO
IPC: G01N13/02
Filed: 1996-09-13
Abstract: The object of the invention is a device for measuring the surface pressure of a film formed at the interface of a liquid and gaseous phase, the device comprising a detector means and a sensor means. The detector means comprises a light source and a position-sensitive detector, the active surface of which is situated in the light beam of the light source, and the sensor means comprises a sensor which can be brought into contact with the film to be measured, and a shading means which, in correspondence with the force applied to the sensor by the film, moves in the light beam between the active surface of the detector and the light source.
Patent FI-972647-A0 (FI)
Inventor: GRANDMAIRE JEAN-PAUL
IPC: D06M13/322
Filed: 1997-06-19
Abstract: Clear fabric softener microemulsion compositions have been developed for use in the rinse cycle comprising a combination of diester quaternary ammonium surfactants, diamido ammonium surfactants and selected organic solvents. Fatty co-softeners and oil perfumes may be included as optional ingredients. These microemulsions are converted to macroemulsions upon dilution with water in the rinse cycle to provide a fabric softening treatment.
Patent IL-63255-A0 (IL)
Title: Synergistic herbicidal compositions comprising a phenoxypropionic acid ester derivatives and another herbicide
IPC: A01N47/30
Filed: 1981-07-08
Abstract: 1. A synergistic composition for selectively controlling weeds, which composition comprises, on the one hand, a 4-(3',5'-dichloropyridyl-2'oxy)-alpha-phenoxypropionic acid propargyl ester of the formula I  see diagramm : EP0043802,P15,F1  wherein Z is oxygen or sulfur, and, on the other, one of 3-(3'-chloro-4'-methylphenyl)1,1-dimethylurea (IIa), 3-(3'-chloro-4'-methoxyphenyl)-1,1-dimethylurea (IIb), 3-(4'-isopropylphenyl)-1,1-dimethylurea (IIc), 1-benzothiazol-2-yl-1,3-dimethylurea (IId), 4-hydroxy-3,5-diiodobenzonitrile (IIe) or 3,5-dibromo-4-hydroxybenzaldehyde-O-(2',4' -dinitrophenyl)-oxime (IIf), together whith carriers and/or other adjuvants.
Patent IL-63407-A0 (IL)
Title: Benzophenone derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P5/38
Filed: 1981-07-24
Abstract: There is presented novel benzophenone derivatives of the formula <IMAGE>  I  wherein R1 is hydrogen or lower alkyl, R2 is hydrogen or aminoacetyl, R3 is hydrogen or lower alkyl, R4 is hydrogen or halogen, R5 is hydrogen, amino, nitro or a group of the formula R3-ON=C(R6)-and R6 is lower alkyl, with the proviso that R5 is a group of the formula H-ON=C(R6)-when R2 and R3 are both hydrogen, and their pharmaceutically acceptable acid addition salts. The compounds exhibit aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, hepatic ascites, primary aldosteronism and idiopathic hypertension.
Patent IL-80407-A0 (IL)
Title: Novel plant plasmid vector
IPC: C12P21/00
Filed: 1986-10-24
Abstract: The invention relates to novel plant plasmid vectors comprising geminivirus DNA or a portion thereof having inserted therein a heterologous DNA sequence or gene, to processes and DNA intermediates useful in producing said vectors and to methods utilizing such vectors to replicate and express heterologous DNA sequences or genes in plants. In some embodiments, methods and compositions are provided for Ti plasmid delivery of these novel vectors into plants. In other embodiments, methods and compositions are provided which allow for the generation of geminivirus DNA containing plant plasmids in stably transformed plants. In still other embodiments, methods and compositions are provided for replicating and expressing heterologous DNA sequences or genes in plants employing the geminivirus DNA containing vectors of the present invention without causing disease symptoms.
Patent IL-95443-A0 (IL)
Title: Disubstituted(quinolin-2-yl-methoxy)phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/47
Filed: 1990-08-21
Abstract: Disubstituted (quinolin-2-ylmethoxy)phenylacetic acid derivatives can be prepared by reduction of correspondingly disubstituted ketoesters by means of Grignard reagents and, for the preparation of the thio compounds, by subsequent reaction with thiols. The compounds can be used as active substances in medicaments.
Patent FI-20030797-A0 (FI)
Inventor: LILLQVIST ROY
IPC: G06F17/30
Filed: 2003-05-27
Abstract: The invention relates to a mechanism for enhancing database performance in a Domain Name System (DNS). In order to optimize the performance of current de-facto DNS name servers for queries that request data related to a E.164 number, a domain name received in a first format is converted into a second format before it is supplied to database operations. In the second format at least two successive labels of the domain name are combined to form a single label. The conversion may be made in connection with a zone transfer and in connection with a subsequent DNS query.
Patent IL-107184-A0 (IL)
Title: Heterocyclic ether compounds that enhance cognitive function
IPC: A61K31/497
Filed: 1993-10-04
Abstract: Novel heterocyclic ether compounds of formula (I), wherein A, B and R<2> are specifically defined, or pharmaceutically-acceptable salts or prodrugs thereof, which are selective and potent ligands at cholinergic channel receptors, useful in the treatment of cognitive, neurological and mental disorders characterized by decreased cholinergic function.
Patent IL-114202-A0 (IL)
Title: Thermal safety armature for automatic shut-off of cables
IPC: F16K17/38
Filed: 1995-06-18
Abstract: The invention concerns a thermal safety fitting in which the closure motion of the obturator is longitudinal with respect to the obturator seat. The aim is to avoid lateral excursions of the obturator, while keeping manufacturing costs and structural size as low as possible. The obturator (12) is held in the open position in the housing (1) on the longitudinal axis of the obturator seat (28) by means of a generally U-shaped element (30). The two arms (9) of the U-shaped element (30) are located in the vicinity of a reduced-diameter section (17) of the obturator (12). The part (13) of the U-shaped element (30) joining the two arms (9) rests against a thermosolder (14). If the thermosolder (14) melts, the arms (9) no longer remain in the reduced-diameter section (17) owing to the change in the position of the U-shaped element (30), and the obturator (12) thus moves into the closed position under the action of a closing spring (24).
Patent IL-117149-A0 (IL)
Title: Muscarinic antagonists
IPC: C07D239/34
Filed: 1996-02-15
Abstract: Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) wherein R, R1, R2, R3, R4, R21, R27, R28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula or other compounds capable of enhancing acetylcholine release with acetylcholinesterase inhibitors.
Patent IL-121165-A0 (IL)
Title: Pharmaceutical compositions containing carboxylic acids and derivatives thereof
IPC: A61P19/02
Filed: 1997-06-26
Abstract: In accordance with the present invention, there are provided therapeutically effective compounds comprising an amphipathic carboxylate of the formula R-COOH, or a salt or an ester or amide of such compound, where R designates a saturated or unsaturated alkyl chain of 10-24 carbon atoms, one or more of which may be replaced by heteroatoms, where one or more of said carbon or heteroatom chain members optionally forms part of a ring, and where said chain is optionally substituted by a hydrocarbyl radical, heterocyclyl radical, lower alkoxy, hydroxyl-substituted lower alkyl, hydroxyl, carboxyl, halogen, phenyl or (hydroxy-, lower alkyl-, lower alkoxy-, lower alkenyl- or lower alkinyl)-substituted phenyl, C3-C7 cycloalkyl or (hydroxy-, lower alkyl-, lower alkoxy-, lower alkenyl- or lower alkinyl)-substituted C3-C7 cycloalkyl wherein said amphipathic carboxylate is capable of being endogenously converted to its respective coenzyme A thioester.
Patent IL-137757-A0 (IL)
Title: Method of controlling proliferation and differentiation of stem and progenitor cells
IPC: C12N5/0789
Filed: 1999-02-08
Abstract: An expanded stem cell population expanded ex-vivo in a culture medium containing at least one copper chelator in an amount for permitting stem cells of said cell population to proliferate and, at the same time, for reducing a capacity of said stem cells to differentiate, said stem cells are hence expanded yet not further differentiated as compared to ex-vivo seeded stem cells from which said cell population developed.
Patent IL-139967-A0 (IL)
Title: β-ALANINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IPC: A61P43/00
Filed: 1999-05-28
Abstract: OMePUPA-V, (R)-N-[[4-[[(2-methylphenylamino)carbonyl]amino]phenyl]acetyl]-L-prolyl-3-methyl)-beta-Alanine, a cell adhesion inhibitor, pharmaceutical compositions, and methods of treatment of cell-adhesion mediated pathologies.
Patent IL-160806-A0 (IL)
Title: Soundproofing and thermally insulating structural element
IPC: B32B5/18
Filed: 2004-03-10
Abstract: Insulation board is of hard polyurethane foam where the closed cells comprise >=90%. Their surfaces form 1-18 recesses/cm2>, with a diameter of 0.1-10.0 mm and a depth of 10-70 mm, on both sides. They form two types of recesses, which differ at least in their dimensions. The outer surfaces of the foam are covered with a foil or a mineral fiber nonwoven, using the same or different claddings on both sides. The insulation board is of a hard polyurethane foam where the closed cells comprise >=90%. Their surfaces form 1-18 recesses/cm2>, with a diameter of 0.1-10.0 mm and a depth of 10-70 mm, on both sides. They form two types of recesses, which differ at least in their dimensions. The outer surfaces of the foam are covered with a foil or a mineral fiber nonwoven, using the same or different claddings on both sides. The polyurethane foam has a density of 20-120 kg/m3> and preferably 20-80 kg/m3> and especially 25-40 kg/m3>.
Patent IL-164384-A0 (IL)
Title: Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
IPC: A61B17/20
Filed: 2003-04-07
Abstract: Disclosed are production of Plasmodium species sporozoites in Anopheles species mosquitoes, specifically; apparatuses and methods for the production of strains of haematophagous insects with desired properties such as hypoallergenicity or hyperinfectivity; methods of producing a parasite strain that is capable of withstanding cyropreservation at temperatures close to freezing; apparatuses and methods for the injection of an attenuated parasite vaccine; production of parasites and haematophagous insects that are free from contamination by unwanted biological agents.
Patent IL-178228-A0 (IL)
Title: A process for the semisynthesis of deserpidine
IPC: C07D459/00
Filed: 2006-09-21
Abstract: The present invention relates to an efficient procedure for the synthesis of deserpidine (Ia), starting from reserpic acid lactone (II) via the intermediate 11-O-demethyl reserpic acid lactone (III).
Patent IL-179621-A0 (IL)
Title: Filter cartridge and device for filtering liquids
IPC: C02F1/00
Filed: 2006-11-27
Abstract: A drinking water filter cartridge (100) is located and secured within a holder. The cartridge has an inlet funnel (10) with a first fixture (30) located below the inlet (13) and a second fixture (130) located below a sealing edge (160). The two fixtures (30, 130) operate in conjunction with each other. The filter cartridge (100) is inserted axially within the inlet (13). The second fixture (130) is located in the lower third of the filter cartridge (100) and locates in a detent in the cartridge base (112). The fixtures (30, 130) are projecting conical nipples or detents. Also claimed is a commensurate water vessel for the drinking water cartridge.
Patent IL-179744-A0 (IL)
Title: Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof
IPC: C12Q1/68
Filed: 2006-11-30
Abstract: The present invention discloses the identification of a human obesity susceptibility gene, which can be used for the diagnosis, prevention and treatment of obesity and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the KCNAB2 gene on chromosome 1 and certain alleles thereof are related to susceptibility to obesity and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the KCNAB2 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and dyslipidemia.
Patent IL-184699-A0 (IL)
Title: A fusion protein comprising a tnf related apoptosis inducing ligand
IPC: C12N15/19
Filed: 2007-07-18
Abstract: A novel cytokine designated TRAIL induces apoptosis of certain target cells, including cancer cells and virally infected cells. Isolated DNA sequences encoding TRAIL are disclosed, along with expression vectors and transformed host cells useful in producing TRAIL polypeptides. Antibodies that specifically bind TRAIL are provided as well.